Patents by Inventor Barbara Alving

Barbara Alving has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5476771
    Abstract: A quantitative method for determining the plasma levels of thrombin-specific inhibitors is based on the quantitative thrombin time using plasma dilutions, excess fibrinogen and thrombin. The plasma dilutions and excess fibrinogen act in concert to eliminate the effects that coagulopathies have on standard coagulation tests. The method is relatively simple and provides superior results to standard conventional tests. The method is suitable for performance in clinical hematology laboratories on a routine basis using commercially available instrumentation.
    Type: Grant
    Filed: February 22, 1993
    Date of Patent: December 19, 1995
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Thomas J. Reid, Barbara Alving
  • Patent number: 5399158
    Abstract: This invention relates to the prevention and treatment of thrombi using pminogen activators, including t-PA, urokinases, and streptokinases, in conjunction with intermittent (pulsed mode) ultrasound. A preferred modality interposes liquid-containing interface between the skin of the patient and the transducer of the ultrasound generator.
    Type: Grant
    Filed: January 27, 1993
    Date of Patent: March 21, 1995
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Carl G. Lauer, Barbara Alving